How is the biomarker guanylyl cyclase 2C helping to predict colorectal cancer recurrence rates? Host Dr. Lee Freedman welcomes Dr. Scott Waldman, professor in the departments of medicine and biochemistry at Thomas Jefferson University, to discuss how this biomarker found in regional lymph nodes can predict the recurrence rate for colorectal cancer patients. How does the presence of metastatic tumor cells predict clinical outcomes?
ReachMD
Be part of the knowledge.™Promising New Biomarker to Predict Colorectal Cancer Recurrence
Choose a format
Media formats available:
Facebook Comments